NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02767804,eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients,https://clinicaltrials.gov/study/NCT02767804,,ACTIVE_NOT_RECRUITING,The primary purpose of this study is to evaluate the efficacy and safety of X-396 (ensartinib) vs. crizotinib in patients with ALK-positive non-small cell lung cancer that have received up to 1 prior chemotherapy regimen and no prior ALK inhibitor.,NO,Non-small Cell Lung Cancer,DRUG: X-396 (ensartinib)|DRUG: crizotinib,"Progression-free survival (PFS), as assessed by independent radiology review based on RECIST v. 1.1 criteria, 36 months","Overall survival (OS), Time in months from date of randomization to death due to any cause, 48 months|CNS response rate, Based on IRR, time to CNS progression (based on IRR), objective response rate (based on IRR), 36 months|ORR based on independent radiology review, The proportion of patients in ITT who have an objective response (i.e., those who achieve a best response of CR or PR) per RECIST 1.1 criteria, 36 months",,"Xcovery Holdings, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,290,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,X396-CLI-301,2016-06,2025-12-30,2025-12-31,2016-05-10,,2024-08-20,"Moffitt Cancer Center, Tampa, Florida, 33612, United States|University Cancer & Blood Center, Athens, Georgia, 30607, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Sanatorio Parque S.A., Rosario, Argentina|Border Medical Oncology Research Unit, Albury, New South Wales, 2640, Australia|Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia|Chris O Brien Lifehouse, Camperdown, Australia|Catholic University of Louvain (UCL) - Site Mont Godinne, Yvoir, 5530, Belgium|Instituto do Câncer do Estado de São Paulo, São Paulo, SP, 01246-000, Brazil|Hospital de Câncer de Barretos - Fundação Pio XII, São Paulo, SP, 14784-400, Brazil|Hospital Haroldo Juaçaba - Instituto do Cancêr do Ceará, Fortaleza, 60351-010, Brazil|Fundacao do ABC Faculdade de Medicina do ABC, São Paulo, Brazil|Infirmière recherche Clinique, IUCPQ, Quebec City, Quebec, G1V 4G5, Canada|Anhui Provincial Hospital, Hefei, Anhui, 230001, China|Beijing Chao Yang Hospital, Beijing, Beijing, 100020, China|Peking Union Medical College Hospital, Beijing, Beijing, 100032, China|Peking University Cancer Hospital, Beijing, Beijing, 100142, China|Beijing Chest Hospital,Capital Medical University, Beijing, Beijing, 101149, China|Fujian Provincial Cancer Hospital, Fuzhou, Fujian, 350014, China|Guangdong General Hospital, Guangzhou, Guangdong, 510080, China|Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China|Union Hospital of Tongji Medical College of Huazhong Science and Techology University, Wuhan, Hubei, 420104, China|Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430030, China|Hubei Cancer Hospital, Wuhan, Hubei, 430079, China|Hunan Cancer Hospital, Changsha, Hunan, 410006, China|Nanjing General Hospital, Nanjing, Jiangsu, 210002, China|The First Bethune Hospital of Jilin University, Changchun, Jilin, 130000, China|Jilin Cancer Hospital, Changchun, Jilin, 130012, China|The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China|The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266071, China|Shanghai Chest Hospital, Shanghai, Shanghai, 200030, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|Peking University Cancer Hospital, Beijing, 100142, China|Zhejiang Cancer Hospital, Hangzhou, China|Vítkovická Nemocnice , a.s., Ostrava-Vitkovice, 70384, Czechia|Krajská zdravotní, a.s., Masarykova nemocnice, Usti nad Labem, 40113, Czechia|CHRU Lille, Lille, 59000, France|Hopital Arnaud de Villeneuve, Montpellier, 34298, France|CHU de Rennes Hôpital Pontchaillou, Rennes, 35033, France|Hopital Saint-Louis, Vellefaux, France|Charite Campus Virchow-Klinikum, Berlin, 13353, Germany|Lungen Clinic Grosshansdorf, Grosshansdorf, 22927, Germany|Prince of Wales Hospital, Hong Kong, Hong Kong|Queen Elizabeth Hospital, Hong Kong, Hong Kong|The University of Hong Kong/Queen Mary Hospital, Hong Kong, Hong Kong|Prince of Wales Hospital, Sha Tin, Hong Kong|Hadassah Medical Center, Jerusalem, 9112001, Israel|Rabin Medical Center Institute of Oncology, Davidoff Center, Petah Tiqva, 49100, Israel|IEO Istituto Europeo di Oncologia, Milano, 20141, Italy|Centro Operativo Studi Clinici S.C.Oncologia Medica, Perugia, 06132, Italy|Azienda Socio Sanitaria Territoriale (ASST) della Valtellina e dell'Alto Laria, Sondrio, 20121, Italy|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|VU Medical Center, Amsterdam, 1007 MB, Netherlands|Maastricht University Medical Centre (MUMC), Maastricht, 6229HX, Netherlands|Medical University of Gdansk, Gdańsk, Poland|Federal State Budgetary Scientific Institution Russian Oncological Scientific Center named after N.N. Blokhin, Moscow, 115478, Russian Federation|LLC ""Vitamed"", Moscow, 121309, Russian Federation|Moscow City Oncology Hospital #63, Moscow, 143423, Russian Federation|BIH of Omsk Region ""Clinical Oncology Dispensary"", Omsk, Russian Federation|Pavlov First Medical University, Saint Petersburg, 197022, Russian Federation|Petrov Research Institute of Oncology, Saint Petersburg, Russian Federation|Hospital del Mar, Barcelona, 08003, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Vall d'Hebrón, Barcelona, 08035, Spain|Hospital Son Ltatzer, Palma de Mallorca, 07198, Spain|Trakya University Balkan Oncology Hospital, Edirne, 22030, Turkey|Blackpool Victoria Hospital, Blackwood, FY3 8NR, United Kingdom|Southmead Hospital, Bristol, BS10 5NB, United Kingdom|Kings Mill Hospital, Nottingham, NG17 4JL, United Kingdom|The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, United Kingdom",
